USD
$0.00
(0.00%
)At Close (As of Sep 5, 2025)
$3.72M
Market Cap
-
P/E Ratio
-47.4
EPS
$1,410.00
52 Week High
$2.13
52 Week Low
HEALTHCARE
Sector
Field | Value (USD) |
---|---|
Gross Profit | $1M |
Total Revenue | $3.4M |
Cost Of Revenue | $2.4M |
Costof Goods And Services Sold | $2.4M |
Operating Income | -$14M |
Selling General And Administrative | $11M |
Research And Development | $3.6M |
Operating Expenses | $15M |
Investment Income Net | - |
Net Interest Income | $176K |
Interest Income | $176K |
Interest Expense | - |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $696K |
Income Before Tax | -$7.1M |
Income Tax Expense | $137K |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$7.1M |
Comprehensive Income Net Of Tax | - |
Ebit | -$14M |
Ebitda | -$13M |
Net Income | -$7M |
Field | Value (USD) |
---|---|
Total Assets | $13M |
Total Current Assets | $8M |
Cash And Cash Equivalents At Carrying Value | $6.4M |
Cash And Short Term Investments | $6.4M |
Inventory | $439K |
Current Net Receivables | $362K |
Total Non Current Assets | $4.7M |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | $2.7M |
Intangible Assets Excluding Goodwill | $2.7M |
Goodwill | - |
Investments | - |
Long Term Investments | - |
Short Term Investments | - |
Other Current Assets | $816K |
Other Non Current Assets | - |
Total Liabilities | $3.8M |
Total Current Liabilities | $2.4M |
Current Accounts Payable | $1.2M |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $1.1M |
Total Non Current Liabilities | $1.4M |
Capital Lease Obligations | $739K |
Long Term Debt | - |
Current Long Term Debt | - |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $739K |
Other Current Liabilities | $82K |
Other Non Current Liabilities | - |
Total Shareholder Equity | $9.1M |
Treasury Stock | - |
Retained Earnings | -$310M |
Common Stock | $10K |
Common Stock Shares Outstanding | $4M |
Field | Value (USD) |
---|---|
Operating Cashflow | -$14M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $696K |
Capital Expenditures | $408K |
Change In Receivables | - |
Change In Inventory | -$109K |
Profit Loss | - |
Cashflow From Investment | -$408K |
Cashflow From Financing | $13M |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | $233K |
Dividend Payout Common Stock | $233K |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | - |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | -$7.1M |
Field | Value (USD) |
---|---|
Gross Profit | $1M |
Total Revenue | $3.4M |
Cost Of Revenue | $2.4M |
Costof Goods And Services Sold | $2.4M |
Operating Income | -$14M |
Selling General And Administrative | $11M |
Research And Development | $3.6M |
Operating Expenses | $15M |
Investment Income Net | - |
Net Interest Income | $176K |
Interest Income | $176K |
Interest Expense | - |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $696K |
Income Before Tax | -$7.1M |
Income Tax Expense | $137K |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$7.1M |
Comprehensive Income Net Of Tax | - |
Ebit | -$14M |
Ebitda | -$13M |
Net Income | -$7M |
Sector: HEALTHCARE
Industry: DIAGNOSTICS & RESEARCH
Applied DNA Sciences, Inc. develops and markets DNA-based technology solutions for use in the pre-clinical drug development and manufacturing markets based on nucleic acid-based in vitro diagnostics; and for supply chain security, anti-counterfeiting, and anti-theft technology applications in the United States, Europe, and Asia. The company is headquartered in Stony Brook, New York.